Jefferies Reports 2Q Sales On Insulet

According to Jefferies, Insulet PODD reported 2Q sales of $32.2mn, largely in-line with expectations. Jefferies said that full year guidance was narrowed to $152-158mn from $150-160mn. “Op expenses took a step up on the Neighborhood integration, but the company remains on track to reach operating cash breakeven by year end.” Insulet closed yesterday at $18.44.